This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, R. Articles by Straubinger, R. M. Search for Related Content PubMed PubMed Citation Articles by Zhou, R. Articles by Straubinger, R. M.

Antivasculature Effects of Doxorubicin-containing Liposomes in an Intracranial Rat Brain Tumor Model

Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, Amherst, New York 14260-1200 [R. M. S.], and Department of Molecular and Cellular Biophysics Roswell Park Cancer Institute, Buffalo, New York 14263 [R. Z., R. M., R. M. S.]

Increased neovascularization and vascular hyperpermeability are integralprocesses in tumors, and various therapeutic strategies seek to reverse the angiogenic phenotype. Long-circulating liposomes extravasate in tumors such as the rat 9L gliosarcoma and accumulate in perivascular areas. Under such conditions, liposome-encapsulated doxorubicin (DOX) provides 30% increase in life span, but free DOX is no more beneficial than a saline control. However, the relationship between drug deposition and therapeutic effect is understood poorly. In the present work, magnetic resonance (MR) and functional MR (fMR) imaging were used for noninvasive, serial evaluation of intracranial 9L tumor responses to repetitive doses of free DOX or DOX in sterically stabilized long-circulating liposomes (SSL-DOX). After multiple doses of SSL-DOX, MR imaging revealed the induction of intratumor hemorrhage in 63–75% of rats (n = 8). No hemorrhage was observed by MR imaging after a single dose of SSL-DOX, in normal brain regions in animals treated with free DOX (n = 3) or in saline controls (n = 9). Histological sections from rats sacrificed immediately after MR imaging verified the putative hemorrhagic regions and revealed necrotic and apoptotic tumor cells surrounding the area of the hemorrhage. fMR maps were obtained by comparing paired images acquired during air and Carbogen (7% CO₂ and 93% oxygen) breathing. These blood oxygenation level-dependent fMR maps showed enhanced image intensity after both single and multiple doses of SSL-DOX, which suggested increased and progressive vascular permeabilization. The results suggest that the breakdown of tumor vasculature induced by SSL-DOX may arise from the perivascular accumulation of liposomes in tumor and cytotoxic effects on tumor vascular endothelium.

This article has been cited by other articles:

				J. H.E. Baker, J. Lam, A. H. Kyle, J. Sy, T. Oliver, S. J. Co, W. H. Dragowska, E. Ramsay, M. Anantha, T. J. Ruth, et al. Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin Clin. Cancer Res., November 15, 2008; 14(22): 7260 - 7271. [Abstract] [Full Text] [PDF]

				M. Demeule, A. Regina, C. Che, J. Poirier, T. Nguyen, R. Gabathuler, J.-P. Castaigne, and R. Beliveau Identification and Design of Peptides as a New Drug Delivery System for the Brain J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1064 - 1072. [Abstract] [Full Text] [PDF]

				Y. Yamashita, M. T. Krauze, T. Kawaguchi, C. O. noble, D. C. Drummond, J. W. Park, and K. S. Bankiewicz Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts Neuro-oncol, January 1, 2007; 9(1): 20 - 28. [Abstract] [Full Text] [PDF]

				R. D. Arnold, D. E. Mager, J. E. Slack, and R. M. Straubinger Effect of Repetitive Administration of Doxorubicin-Containing Liposomes on Plasma Pharmacokinetics and Drug Biodistribution in a Rat Brain Tumor Model Clin. Cancer Res., December 15, 2005; 11(24): 8856 - 8865. [Abstract] [Full Text] [PDF]